JP2011520808A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011520808A5 JP2011520808A5 JP2011508574A JP2011508574A JP2011520808A5 JP 2011520808 A5 JP2011520808 A5 JP 2011520808A5 JP 2011508574 A JP2011508574 A JP 2011508574A JP 2011508574 A JP2011508574 A JP 2011508574A JP 2011520808 A5 JP2011520808 A5 JP 2011520808A5
- Authority
- JP
- Japan
- Prior art keywords
- sulindac
- usage according
- derivatives
- epimer
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- MLKXDPUZXIRXEP-MFOYZWKCSA-N sulindac Chemical class CC1=C(CC(O)=O)C2=CC(F)=CC=C2\C1=C/C1=CC=C(S(C)=O)C=C1 MLKXDPUZXIRXEP-MFOYZWKCSA-N 0.000 claims 12
- 229960000894 sulindac Drugs 0.000 claims 7
- 210000004027 cell Anatomy 0.000 claims 4
- QEFRNWWLZKMPFJ-ZXPFJRLXSA-N L-methionine (R)-S-oxide Chemical compound C[S@@](=O)CC[C@H]([NH3+])C([O-])=O QEFRNWWLZKMPFJ-ZXPFJRLXSA-N 0.000 claims 2
- QEFRNWWLZKMPFJ-UHFFFAOYSA-N L-methionine sulphoxide Natural products CS(=O)CCC(N)C(O)=O QEFRNWWLZKMPFJ-UHFFFAOYSA-N 0.000 claims 2
- 206010063837 Reperfusion injury Diseases 0.000 claims 1
- 210000004413 cardiac myocyte Anatomy 0.000 claims 1
- 230000006378 damage Effects 0.000 claims 1
- 208000028867 ischemia Diseases 0.000 claims 1
- 230000003647 oxidation Effects 0.000 claims 1
- 238000007254 oxidation reaction Methods 0.000 claims 1
- 230000004792 oxidative damage Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12/115,331 | 2008-05-05 | ||
| US12/115,331 US8487128B2 (en) | 2002-11-26 | 2008-05-05 | Protection of normal cells |
| PCT/US2009/042703 WO2009137400A2 (en) | 2008-05-05 | 2009-05-04 | Protection of normal cells |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011520808A JP2011520808A (ja) | 2011-07-21 |
| JP2011520808A5 true JP2011520808A5 (https=) | 2012-06-21 |
Family
ID=41265328
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011508574A Pending JP2011520808A (ja) | 2008-05-05 | 2009-05-04 | 正常細胞の保護 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US8487128B2 (https=) |
| EP (1) | EP2282733A4 (https=) |
| JP (1) | JP2011520808A (https=) |
| CN (1) | CN102112124A (https=) |
| AU (1) | AU2009244500A1 (https=) |
| CA (1) | CA2755499A1 (https=) |
| WO (1) | WO2009137400A2 (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8487128B2 (en) * | 2002-11-26 | 2013-07-16 | Chs Pharma, Inc. | Protection of normal cells |
| EP4464384A3 (en) | 2007-08-17 | 2025-01-08 | Purdue Research Foundation | Psma binding ligand-linker conjugates and methods for using |
| US9951324B2 (en) | 2010-02-25 | 2018-04-24 | Purdue Research Foundation | PSMA binding ligand-linker conjugates and methods for using |
| EP2882426A1 (en) * | 2012-08-13 | 2015-06-17 | Institut National de la Santé et de la Recherche Médicale (INSERM) | Methods and pharmaceutical compositions for treatment of cystic fibrosis |
| BR112015011118B1 (pt) | 2012-11-15 | 2022-12-13 | Endocyte, Inc | Conjugado; composição farmacêutica; e uso de um conjugado |
| USRE48077E1 (en) | 2013-02-28 | 2020-07-07 | Anida Pharma Inc. | Methods of treating ototoxicity |
| WO2014160702A1 (en) | 2013-03-25 | 2014-10-02 | Chs Pharma, Inc. | Retinopathy treatment |
| LT4095130T (lt) | 2013-10-18 | 2024-04-25 | Novartis Ag | Žymėti prostatos specifinio membranos antigeno (psma) inhibitoriai, jų naudojimas kaip vizualizavimo medžiagų ir farmacinių medžiagų prostatos vėžiui gydyti |
| BR112016010927A2 (pt) | 2013-11-14 | 2017-08-08 | Endocyte Inc | Conjugado de fórmula |
| US10188759B2 (en) | 2015-01-07 | 2019-01-29 | Endocyte, Inc. | Conjugates for imaging |
| JP6735225B2 (ja) * | 2015-12-25 | 2020-08-05 | 共栄化学工業株式会社 | 皮膚外用組成物及び経口組成物 |
| US11186534B2 (en) * | 2017-03-17 | 2021-11-30 | University Of South Alabama | Derivatives of sulindac can protect normal cells against oxidative damage |
| PL237474B1 (pl) * | 2017-05-04 | 2021-04-19 | Wyzsza Szkola Medyczna W Bialymstoku | Nowe zastosowanie kwasu 2-[(3Z)-6-fluoro-2-metylo-3-[(4-metylosulfinylofenylo) metylideno]inden-1-ylo] octowego |
| US12208102B2 (en) | 2018-04-17 | 2025-01-28 | Endocyte, Inc. | Methods of treating cancer |
| CN114096264B (zh) | 2019-05-20 | 2025-03-14 | 因多塞特股份有限公司 | 制备psma缀合物的方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5053429A (en) * | 1988-04-08 | 1991-10-01 | The Lithox Corporation, Inc. | Treating inflammatory pain with methionine |
| US5401774A (en) * | 1991-03-08 | 1995-03-28 | University Of Arizona | Method for treating patients with precancerous lesions by administering substituted sulfonyl idenyl acetic and propionic acids and esters to patients with lesions sensitive to such compounds |
| US5608067A (en) * | 1993-12-09 | 1997-03-04 | Afonso; Adriano | 4-substituted pyrazoloquinoline derivatives |
| US6201028B1 (en) * | 1998-12-08 | 2001-03-13 | The Rockefeller University | Methods and compositions for prevention and treatment of atherosclerosis and hyperlipidemia with non-steroidal anti-inflammatory drugs |
| EP1469884A1 (en) * | 2002-01-30 | 2004-10-27 | Pharmacia Corporation | Aldosterone antagonist and non-steroidal anti-inflammatory agent combination therapy to prevent or treat cardiovascular disorders |
| US8487128B2 (en) * | 2002-11-26 | 2013-07-16 | Chs Pharma, Inc. | Protection of normal cells |
| AU2003298020A1 (en) * | 2002-11-26 | 2004-06-18 | Florida Atlantic University | Catalytic antioxidants and methods of use |
| US20090312238A1 (en) | 2006-05-03 | 2009-12-17 | Florida Atlantic University | Protection Against Oxidative Damage in Cells |
-
2008
- 2008-05-05 US US12/115,331 patent/US8487128B2/en not_active Expired - Fee Related
-
2009
- 2009-05-04 WO PCT/US2009/042703 patent/WO2009137400A2/en not_active Ceased
- 2009-05-04 CN CN2009801268109A patent/CN102112124A/zh active Pending
- 2009-05-04 EP EP09743387A patent/EP2282733A4/en not_active Withdrawn
- 2009-05-04 CA CA2755499A patent/CA2755499A1/en not_active Abandoned
- 2009-05-04 JP JP2011508574A patent/JP2011520808A/ja active Pending
- 2009-05-04 AU AU2009244500A patent/AU2009244500A1/en not_active Abandoned
-
2013
- 2013-07-16 US US13/943,218 patent/US8871971B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011520808A5 (https=) | ||
| DE602008001332D1 (de) | Batterieelektrode | |
| EP2193569A4 (en) | BATTERIES WITH INORGANIC / ORGANIC POROUS FILMS | |
| BRPI0819271A2 (pt) | bateria de chumbo-ácido | |
| DE112006004198A5 (de) | Herstellung eines Wirkleistungsgleichgewichts der Phasenmodule eines Umrichters | |
| JP2010505891A5 (https=) | ||
| DE602008002006D1 (de) | Batteriepack | |
| BRPI0922356A2 (pt) | bateria sólida | |
| EP2251926A4 (en) | NONAQUEOUS ELECTROLYTE FOR LITHIUM BATTERY, LITHIUM BATTERY IN WHICH SAID ELECTROLYTE IS USED AND HYDROXY ACID DERIVED FOR USE IN SAID ELECTROLYTE | |
| EP2524715A4 (en) | OXYGEN | |
| DE602006018682D1 (de) | Elektrodenanordnung für Lithiumionenbatterie | |
| ATE530523T1 (de) | (3-amino-1,2,3,4-tetrahydro-9h-carbazol-9-yl)- essigsäurederivate | |
| EP2367808A4 (en) | PROGESTATIVE 3- (6,6-ETHYLENE-17b-HYDROXY-3-OXO-17a-PREGNA-4-EN-17a-YL) PROPIONIC ACID g-LACTONE | |
| EP2320494A4 (en) | Lead storage battery | |
| DE602008000580D1 (de) | Batteriepack | |
| DE602008002604D1 (de) | Hybridbatterie | |
| EP2183247A4 (en) | NEW CRYSTALLINE FORMS OF 2-HYDROXY-3- [5- (MORPHOLIN-4-YLMETHYL) PYRIDIN-2-YL] IH-INDOL-5-CARBONITRILE CITRATE | |
| EP1928051A4 (en) | THIN FILM LITHIUM BATTERY | |
| DE602006018404D1 (de) | Batteriepack | |
| EP2104174A4 (en) | LITHIUM SECONDARY BATTERY ION | |
| EP2460795A4 (en) | FULLER DERIVATIVES | |
| DK2184999T3 (da) | Tørrevogn | |
| EP1898468A4 (en) | CELL FOR SOLAR CELL | |
| JP2013512203A5 (https=) | ||
| EP2471792A4 (en) | 3- (BIARYLOXY-) propionic acid |